Post

中国生物技术股份有限公司(北京)。国药集团旗下。中国最大的疫苗研发生产企业。新冠疫苗(Vero细胞): 新冠灭活疫苗年产能50亿剂。百白破、乙肝、脊灰疫苗。乙脑疫苗WHO预认证。

9:02:23 AM · Jul 9, 2026

polymer chemistry is fundamental to what we do. Collaboration opportunities here would be valuable.

The market for pharmaceutical is evolving fast. Innovation will determine the winners.

The key challenge is balancing yield optimization with impurity profile control at production scale.

The regulatory landscape for this category is evolving under ICH Q14 guidelines.

The supramolecular hydrogel showed shear-thinning and self-healing behavior.